Alpha Teknova, Inc. (TKNO)
USD 5.67
(1.43%)
USD 5.67
(1.43%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.97 Million USD | 2567.57% |
| 2022 | 74 Thousand USD | 100.1% |
| 2021 | -75.64 Million USD | -2181.99% |
| 2020 | -3.31 Million USD | 19.13% |
| 2019 | -4.09 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 12.37 Million USD | 26.78% |
| 2024 Q1 | 9.76 Million USD | 394.63% |
| 2023 Q1 | 10.7 Million USD | 14363.51% |
| 2023 Q3 | -1.26 Million USD | -107.67% |
| 2023 FY | 1.97 Million USD | 2567.57% |
| 2023 Q2 | 16.52 Million USD | 54.4% |
| 2023 Q4 | 1.97 Million USD | 255.68% |
| 2022 Q3 | -13.89 Million USD | 50.93% |
| 2022 FY | 74 Thousand USD | 100.1% |
| 2022 Q4 | 74 Thousand USD | 100.53% |
| 2022 Q2 | -28.31 Million USD | 36.38% |
| 2022 Q1 | -44.5 Million USD | 41.17% |
| 2021 FY | -75.64 Million USD | -2181.99% |
| 2021 Q3 | -86.18 Million USD | 10.45% |
| 2021 Q2 | -96.24 Million USD | -3425.27% |
| 2021 Q1 | -2.73 Million USD | 17.65% |
| 2021 Q4 | -75.64 Million USD | 12.23% |
| 2020 Q4 | -3.31 Million USD | 0.0% |
| 2020 Q1 | 9.67 Million USD | 0.0% |
| 2020 FY | -3.31 Million USD | 19.13% |
| 2019 FY | -4.09 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 99.547% |
| Embecta Corp. | 1.31 Billion USD | 99.85% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | 97.905% |
| Dynavax Technologies Corporation | 106.63 Million USD | 98.149% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 99.57% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 99.544% |
| PainReform Ltd. | -7.95 Million USD | 124.83% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | 97.366% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 112.626% |
| SCYNEXIS, Inc. | -19.35 Million USD | 110.202% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 120.934% |
| Cosmos Health Inc. | 8.59 Million USD | 77.022% |
| Journey Medical Corporation | -9.7 Million USD | 120.332% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 112.626% |
| Safety Shot Inc | -2.28 Million USD | 186.413% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 101.509% |
| Bright Green Corporation | 1.84 Million USD | -7.182% |
| Procaps Group, S.A. | 242.93 Million USD | 99.187% |
| Theratechnologies Inc. | 24.87 Million USD | 92.063% |
| Harrow Health, Inc. | 116.41 Million USD | 98.304% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | 178.333% |
| Biofrontera Inc. | 4.05 Million USD | 51.331% |
| DURECT Corporation | -7.65 Million USD | 125.79% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 105.888% |
| Cronos Group Inc. | -663.32 Million USD | 100.298% |
| OptiNose, Inc. | 58.06 Million USD | 96.6% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 99.683% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 113.547% |
| RedHill Biopharma Ltd. | -5.18 Million USD | 138.064% |
| Organogenesis Holdings Inc. | 15.01 Million USD | 86.851% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | 131.039% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | -1747.294% |
| Radius Health, Inc. | 359.28 Million USD | 99.451% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | -900.969% |
| ProPhase Labs, Inc. | 19.23 Million USD | 89.735% |
| Phibro Animal Health Corporation | 454.84 Million USD | 99.566% |
| Procaps Group S.A. | 242.93 Million USD | 99.187% |
| Alvotech | 1.06 Billion USD | 99.815% |
| TherapeuticsMD, Inc. | 3.67 Million USD | 46.33% |
| Viatris Inc. | 17.13 Billion USD | 99.988% |
| Rockwell Medical, Inc. | 4.45 Million USD | 55.7% |
| Aytu BioPharma, Inc. | -4.87 Million USD | 140.476% |
| SIGA Technologies, Inc. | -148.68 Million USD | 101.328% |
| Tilray Brands, Inc. | 158.97 Million USD | 98.758% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | 98.381% |
| Shineco, Inc. | 29.29 Million USD | 93.261% |
| PetIQ, Inc. | 351.93 Million USD | 99.439% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | 168.035% |
| Incannex Healthcare Limited | -5.48 Million USD | 135.989% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | 98.887% |
| Alimera Sciences, Inc. | 55.3 Million USD | 96.431% |
| Silver Spike Investment Corp. | -32.61 Million USD | 106.053% |
| Assertio Holdings, Inc. | -32.52 Million USD | 106.068% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | 232.597% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | 139.009% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | 141.005% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 124.034% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | 53.189% |
| Hempacco Co., Inc. | 13.61 Million USD | 85.501% |
| Talphera, Inc. | -5.72 Million USD | 134.504% |
| Alvotech | 1.06 Billion USD | 99.815% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | 72.372% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 102.041% |
| Currenc Group, Inc. | -16.57 Million USD | 111.911% |
| Kamada Ltd. | -46.43 Million USD | 104.251% |
| Indivior PLC | -33.95 Million USD | 105.814% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | -657.558% |
| Flora Growth Corp. | -713 Thousand USD | 376.858% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 124.034% |
| Evolus, Inc. | 63.7 Million USD | 96.901% |
| HUTCHMED (China) Limited | -197.45 Million USD | 101.0% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 99.588% |
| Akanda Corp. | 3.9 Million USD | 49.448% |